KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Total Debt (2022 - 2025)

Historic Total Debt for Adaptive Biotechnologies (ADPT) over the last 4 years, with Q3 2025 value amounting to $131.8 million.

  • Adaptive Biotechnologies' Total Debt fell 64.96% to $131.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $131.8 million, marking a year-over-year decrease of 64.96%. This contributed to the annual value of $133.3 million for FY2024, which is 200.44% up from last year.
  • Per Adaptive Biotechnologies' latest filing, its Total Debt stood at $131.8 million for Q3 2025, which was down 64.96% from $133.6 million recorded in Q2 2025.
  • Adaptive Biotechnologies' Total Debt's 5-year high stood at $133.6 million during Q2 2025, with a 5-year trough of $125.4 million in Q4 2022.
  • Over the past 4 years, Adaptive Biotechnologies' median Total Debt value was $132.0 million (recorded in 2024), while the average stood at $131.5 million.
  • Per our database at Business Quant, Adaptive Biotechnologies' Total Debt soared by 422.78% in 2023 and then tumbled by 64.96% in 2025.
  • Over the past 4 years, Adaptive Biotechnologies' Total Debt (Quarter) stood at $125.4 million in 2022, then rose by 4.23% to $130.7 million in 2023, then grew by 2.0% to $133.3 million in 2024, then fell by 1.08% to $131.8 million in 2025.
  • Its Total Debt stands at $131.8 million for Q3 2025, versus $133.6 million for Q2 2025 and $133.6 million for Q1 2025.